:
Retatrutide also produced a dysesthesia signal (8.820.9% at Phase 3 doses) the same new side effect now appearing with high-dose semaglutide, and its emergence in two separate next-generation drugs is a pattern worth watching
If you experience persistent headaches, fatigue, mood changes, and other symptoms that dont resolve within a few days, contact your prescribing clinician immediately to assess your condition and prevent possible complications
We use Semaglutide to support glucose control and/or weight management by mimicking the hormone GLP-1, which helps you feel fuller, slows stomach emptying and regulates appetite
Semaglutide Weight Loss Dosage Chart: Everything You Need to Know FDA notice on Wegovy/Ozempic shortage: On February 21st, 2025, the U.S
Zepbound is FDA-approved for once-weekly administration